In a filing, Halozyme Therapeutics Inc revealed its SVP, CHIEF FINANCIAL OFFICER LaBrosse Nicole unloaded Company’s shares for reported $0.17
Halozyme Therapeutics Inc’s recently made public that its SVP, CHIEF FINANCIAL OFFICER LaBrosse Nicole unloaded Company’s shares for reported $1.51
Halozyme Therapeutics Inc’s recent filing unveils that its PRESIDENT AND CEO Torley Helen unloaded Company’s shares for reported $1.49 million
Halozyme Therapeutics Inc’s recent filing unveils that its Director Connaughton Bernadette unloaded Company’s shares for reported $0.29 million on Sep
Halozyme Therapeutics Inc’s filing revealed that its PRESIDENT AND CEO Torley Helen unloaded Company’s shares for reported $1.29 million on
Halozyme Therapeutics Inc’s filing revealed that its PRESIDENT AND CEO Torley Helen unloaded Company’s shares for reported $1.29 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Halozyme Therapeutics Inc revealed its PRESIDENT AND CEO Torley Helen unloaded Company’s shares for reported $1.15 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Halozyme Therapeutics Inc’s recently made public that its PRESIDENT AND CEO Torley Helen unloaded Company’s shares for reported $1.15 million